Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive (in shares).

 

 

 

Three Months Ended March 31,

 

 

2026

 

 

2025

 

Stock options

 

 

4,559,584

 

 

 

4,640,782

 

Warrants

 

 

1,000,000

 

 

 

4,625,000

 

Convertible notes

 

 

50,348,985

 

 

 

46,982,346

 

Total anti-dilutive instrument

 

 

55,908,569

 

 

 

56,248,128